NEW YORK, April 19, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Vascular Stents Market 2012-2016
http://www.reportlinker.com/p01162210/Global-Vascular-Stents-Market-2012-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Surgical_Equipment
TechNavio's analysts forecast the Global Vascular Stents Market to grow at a CAGR of 8.21 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing prevalence of cardiovascular disease. The Global Vascular Stents Market has also been witnessing the trend of increasing demand for minimally invasive procedures. However, availability of alternative therapies could pose a challenge to the growth of this market.
TechNavio's report, the Global Vascular Stents market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Vascular Stents market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space Abbott Laboratories, Medtronic Inc., Boston Scientific Corp., and Cordis Corp.
Other vendors mentioned in the report are
MicroPort Scientific Corp., Cook Medical, Biosensors International Ltd., and B. Braun Melsungen AG, Allvivo Vascular Inc., Arterial Remodeling Technologies, Biocompatibles Ltd., Biotronik KG, Blue Medical, Cook Medical Inc., Devax Inc., Endovasc Inc., Goodman Co. Ltd., InnoCore Technologies BV, MIV Therapeutics Inc., Reva Medical Inc., Stentys SA, SurModics Inc., Translumina GmbH, X-Cell Medical Inc. and Xtent Inc.
Key questions answered in this report:
What will the market size be in 2016 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and weaknesses of each of these key vendors?
Methodology
1. Executive Summary 2. List of Abbreviations 3. Introduction 4. Scope of the Report Market Overview Product Offerings 5. Market Landscape 5.1. Market Size and Forecast 5.2. Market Segmentation by Category 5.3. Market Segmentation by Delivery Platform 5.4. Global Coronary Stents Market Market Size and Forecast Geographical Segmentation Market Segmentation 5.5. Global Drug Eluting Stents Market Market Size and Forecast 5.6. Global Bare Metal Stents Market Market Size and Forecast 5.7. Global Peripheral Vascular Stents Market Market Size and Forecast 5.8. Global Carotid Artery Stents Market Market Size and Forecast 5.9. Five Forces Analysis 6. Geographical Segmentation 7. Key Leading Countries 8. Vendor Landscape 9. Buying Criteria 10. Market Growth Drivers 11. Drivers and their Impact 12. Market Challenges 13. Impact of Drivers and Challenges 14. Market Trends 15. Key Vendor Analysis 15.1. Abbott Laboratories 15.1.1. Business Overview 15.1.2. Key Information 15.1.3. SWOT Analysis 15.2. Medtronic Inc. 15.2.1. Business Overview 15.2.2. Business Segmentation 15.2.3. Key Information 15.2.4. SWOT Analysis 15.3. Boston Scientific Corp. 15.3.1. Business Overview 15.3.2. Key Information 15.3.3. SWOT Analysis 15.4. Cordis Corp. 15.4.1. Business Overview 15.4.2. Business Segmentation 15.4.3. Key Information 15.4.4. SWOT Analysis 16. Other Reports in this Series
List of Exhibits:
Exhibit 2: Global Vascular Stents Market by Category Segmentation
Exhibit 3: Global Vascular Stents Market by Category Segmentation 2012
Exhibit 4: Global Vascular Stents Market Segmentation by Delivery Platform
Exhibit 5: Global Coronary Stents Market 2012-2016 (US$ billion)
Exhibit 6: Global Coronary Stents Market by Geographical Segmentation2012
Exhibit 7: Global Coronary Stents Market Segmentation
Exhibit 8: Global Coronary Stents Market by Product Segmentation 2012
Exhibit 9: Global Coronary Stents Market by Product Segmentation 2016
Exhibit 10: Global Drug Eluting Stents Market 2012-2016 (US$ billion)
Exhibit 11: Global Bare Metal Stents Market 2012-2016 (US$ billion)
Exhibit 12: Global Peripheral Vascular Stents Market 2012-2016 (US$ billion)
Exhibit 13: Global Carotid Artery Stents Market 2012-2016 (US$ billion)
Exhibit 14: Global Vascular Stents Market by Geographical Segmentation 2012
Exhibit 15: Global Vascular Stents Market by Vendor Segmentation 2012
Exhibit 16: Business Segmentation of Abbott Laboratories
Exhibit 17: Business Segmentation of Medtronic Inc.
Exhibit 18: Business Segmentation of Boston Scientific Corp.
Exhibit 19: Business Segmentation of Cordis Corp.
To order this report:Surgical_Equipment Industry: Global Vascular Stents Market 2012-2016
Contact Clare: [email protected]
US:(339) 368 6001
Intl:+1 339 368 6001
SOURCE Reportlinker
Share this article